-DOCSTART- -X- O
INTRODUCTION -X- _ O
: -X- _ O
The -X- _ O
purpose -X- _ O
of -X- _ O
the -X- _ O
study -X- _ O
was -X- _ O
to -X- _ O
assess -X- _ O
the -X- _ O
long -X- _ O
term -X- _ O
outcome -X- _ O
and -X- _ O
quality -X- _ O
of -X- _ O
life -X- _ O
of -X- _ O
patients -X- _ B-Patient
with -X- _ I-Patient
acute -X- _ I-Patient
respiratory -X- _ I-Patient
distress -X- _ I-Patient
syndrome -X- _ I-Patient
( -X- _ I-Patient
ARDS -X- _ I-Patient
) -X- _ I-Patient
receiving -X- _ B-Intervention
extracorporeal -X- _ I-Intervention
membrane -X- _ I-Intervention
oxygenation -X- _ I-Intervention
( -X- _ I-Intervention
ECMO -X- _ I-Intervention
) -X- _ I-Intervention
for -X- _ I-Intervention
refractory -X- _ I-Intervention
hypoxemia. -X- _ I-Intervention
METHODS -X- _ O
: -X- _ O
A -X- _ O
retrospective -X- _ O
observational -X- _ O
study -X- _ O
with -X- _ O
prospective -X- _ O
health -X- _ O
related -X- _ O
quality -X- _ O
of -X- _ O
life -X- _ O
( -X- _ O
HRQoL -X- _ O
) -X- _ O
assessment -X- _ O
was -X- _ O
conducted -X- _ O
in -X- _ O
ARDS -X- _ B-Patient
patients -X- _ I-Patient
who -X- _ O
had -X- _ B-Intervention
ECMO -X- _ I-Intervention
as -X- _ O
a -X- _ O
rescue -X- _ O
therapy -X- _ O
for -X- _ O
reversible -X- _ O
refractory -X- _ O
hypoxemia -X- _ O
from -X- _ O
January -X- _ O
2009 -X- _ O
until -X- _ O
April -X- _ O
2011 -X- _ O
in -X- _ O
a -X- _ O
tertiary -X- _ O
Australian -X- _ O
centre. -X- _ O
Survival -X- _ O
and -X- _ O
long- -X- _ O
term -X- _ O
quality -X- _ O
of -X- _ O
life -X- _ O
assessment -X- _ O
, -X- _ O
using -X- _ O
the -X- _ O
Short-Form -X- _ O
36 -X- _ O
( -X- _ O
SF-36 -X- _ O
) -X- _ O
and -X- _ O
the -X- _ O
EuroQol -X- _ O
health -X- _ O
related -X- _ O
quality -X- _ O
of -X- _ O
life -X- _ O
questionnaire -X- _ O
( -X- _ O
EQ5D -X- _ O
) -X- _ O
were -X- _ O
assessed -X- _ O
and -X- _ O
compared -X- _ O
to -X- _ O
international -X- _ O
data -X- _ O
from -X- _ O
other -X- _ O
research -X- _ O
groups. -X- _ O
RESULTS -X- _ O
: -X- _ O
Twenty-one -X- _ B-Patient
patients -X- _ I-Patient
( -X- _ I-Patient
mean -X- _ I-Patient
age -X- _ I-Patient
36.3 -X- _ I-Patient
years -X- _ I-Patient
) -X- _ I-Patient
with -X- _ I-Patient
ARDS -X- _ I-Patient
receiving -X- _ B-Intervention
ECMO -X- _ I-Intervention
for -X- _ I-Intervention
refractory -X- _ I-Intervention
hypoxemia -X- _ I-Intervention
were -X- _ O
studied. -X- _ O
Eighteen -X- _ O
( -X- _ O
86 -X- _ O
% -X- _ O
) -X- _ O
patients -X- _ O
were -X- _ O
retrieved -X- _ O
from -X- _ O
external -X- _ O
intensive -X- _ O
care -X- _ O
units -X- _ O
( -X- _ O
ICUs -X- _ O
) -X- _ O
by -X- _ O
a -X- _ O
dedicated -X- _ O
ECMO -X- _ O
retrieval -X- _ O
team. -X- _ O
Eleven -X- _ B-Outcome
( -X- _ I-Outcome
55 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
had -X- _ I-Outcome
H1N1 -X- _ I-Outcome
influenza -X- _ I-Outcome
A-associated -X- _ I-Outcome
pneumonitis. -X- _ I-Outcome
Eighteen -X- _ I-Outcome
( -X- _ I-Outcome
86 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
patients -X- _ I-Outcome
survived -X- _ I-Outcome
to -X- _ I-Outcome
hospital -X- _ I-Outcome
discharge. -X- _ I-Outcome
Of -X- _ I-Outcome
the -X- _ I-Outcome
18 -X- _ I-Outcome
survivors -X- _ I-Outcome
, -X- _ I-Outcome
ten -X- _ I-Outcome
( -X- _ I-Outcome
56 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
were -X- _ I-Outcome
discharged -X- _ I-Outcome
to -X- _ I-Outcome
other -X- _ I-Outcome
hospitals -X- _ I-Outcome
and -X- _ I-Outcome
8 -X- _ I-Outcome
( -X- _ I-Outcome
44 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
were -X- _ I-Outcome
discharged -X- _ I-Outcome
directly -X- _ I-Outcome
home. -X- _ I-Outcome
Sequelae -X- _ I-Outcome
and -X- _ I-Outcome
health -X- _ I-Outcome
related -X- _ I-Outcome
quality -X- _ I-Outcome
of -X- _ I-Outcome
life -X- _ I-Outcome
were -X- _ I-Outcome
evaluated -X- _ I-Outcome
for -X- _ I-Outcome
15 -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
18 -X- _ I-Outcome
( -X- _ I-Outcome
71 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
long-term -X- _ I-Outcome
survivors -X- _ I-Outcome
( -X- _ I-Outcome
assessment -X- _ I-Outcome
at -X- _ I-Outcome
median -X- _ I-Outcome
8 -X- _ I-Outcome
months -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Mean -X- _ I-Outcome
SF-36 -X- _ I-Outcome
scores -X- _ I-Outcome
were -X- _ I-Outcome
significantly -X- _ I-Outcome
lower -X- _ I-Outcome
across -X- _ I-Outcome
all -X- _ I-Outcome
domains -X- _ I-Outcome
compared -X- _ I-Outcome
to -X- _ I-Outcome
age -X- _ I-Outcome
and -X- _ I-Outcome
sex -X- _ I-Outcome
matched -X- _ I-Outcome
Australian -X- _ I-Outcome
norms. -X- _ I-Outcome
Mean -X- _ I-Outcome
SF-36 -X- _ I-Outcome
scores -X- _ I-Outcome
were -X- _ I-Outcome
lower -X- _ I-Outcome
( -X- _ I-Outcome
minimum -X- _ I-Outcome
important -X- _ I-Outcome
difference -X- _ I-Outcome
at -X- _ I-Outcome
least -X- _ I-Outcome
5 -X- _ I-Outcome
points -X- _ I-Outcome
) -X- _ I-Outcome
than -X- _ I-Outcome
previously -X- _ I-Outcome
described -X- _ I-Outcome
ARDS -X- _ I-Outcome
survivors -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
domains -X- _ I-Outcome
of -X- _ I-Outcome
general -X- _ I-Outcome
health -X- _ I-Outcome
, -X- _ I-Outcome
mental -X- _ I-Outcome
health -X- _ I-Outcome
, -X- _ I-Outcome
vitality -X- _ I-Outcome
and -X- _ I-Outcome
social -X- _ I-Outcome
function. -X- _ I-Outcome
One -X- _ I-Outcome
patient -X- _ I-Outcome
had -X- _ I-Outcome
long-term -X- _ I-Outcome
disability -X- _ I-Outcome
as -X- _ I-Outcome
a -X- _ I-Outcome
result -X- _ I-Outcome
of -X- _ I-Outcome
ICU -X- _ I-Outcome
acquired -X- _ I-Outcome
weakness. -X- _ I-Outcome
Only -X- _ I-Outcome
26 -X- _ I-Outcome
% -X- _ I-Outcome
of -X- _ I-Outcome
survivors -X- _ I-Outcome
had -X- _ I-Outcome
returned -X- _ I-Outcome
to -X- _ I-Outcome
previous -X- _ I-Outcome
work -X- _ I-Outcome
levels -X- _ I-Outcome
at -X- _ I-Outcome
the -X- _ I-Outcome
time -X- _ I-Outcome
of -X- _ I-Outcome
follow-up. -X- _ I-Outcome
CONCLUSIONS -X- _ O
: -X- _ O
This -X- _ O
ARDS -X- _ B-Outcome
cohort -X- _ I-Outcome
had -X- _ I-Outcome
a -X- _ I-Outcome
high -X- _ I-Outcome
survival -X- _ I-Outcome
rate -X- _ I-Outcome
( -X- _ I-Outcome
86 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
after -X- _ I-Outcome
use -X- _ I-Outcome
of -X- _ I-Outcome
ECMO -X- _ I-Outcome
support -X- _ I-Outcome
for -X- _ I-Outcome
reversible -X- _ I-Outcome
refractory -X- _ I-Outcome
hypoxemia. -X- _ I-Outcome
Long -X- _ I-Outcome
term -X- _ I-Outcome
survivors -X- _ I-Outcome
had -X- _ I-Outcome
similar -X- _ I-Outcome
physical -X- _ I-Outcome
health -X- _ I-Outcome
but -X- _ I-Outcome
decreased -X- _ I-Outcome
mental -X- _ I-Outcome
health -X- _ I-Outcome
, -X- _ I-Outcome
general -X- _ I-Outcome
health -X- _ I-Outcome
, -X- _ I-Outcome
vitality -X- _ I-Outcome
and -X- _ I-Outcome
social -X- _ I-Outcome
function -X- _ I-Outcome
compared -X- _ I-Outcome
to -X- _ I-Outcome
other -X- _ I-Outcome
ARDS -X- _ I-Outcome
survivors -X- _ I-Outcome
and -X- _ I-Outcome
an -X- _ I-Outcome
unexpectedly -X- _ I-Outcome
poor -X- _ I-Outcome
return -X- _ I-Outcome
to -X- _ I-Outcome
work -X- _ I-Outcome
. -X- _ O

